Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the ...

B. Joy Snider's clinic focuses on early detection of memory issues, using biomarkers for precise Alzheimer's diagnosis and ...

A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Proactive system change is vital to protect both public health and resources. In the context of Alzheimer's Disease, how are ...

Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

Since the identification of Apolipoprotein E (APOE) ε4 as the strongest genetic risk factor for Alzheimer's Disease (AD), it has served as a critical marker for predicting disease susceptibility.

The holidays can be especially tough for those facing Alzheimer’s. Experts say early diagnosis is key, with new treatments offering hope and more time with family.

A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...